UBS Group AG - APPLIED GENETIC TECHNOL CORP ownership

APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 69 filers reported holding APPLIED GENETIC TECHNOL CORP in Q4 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of APPLIED GENETIC TECHNOL CORP
ValueSharesWeighting
Q3 2022$16,000
+77.8%
58,766
+398.2%
0.00%
Q2 2022$9,000
+28.6%
11,795
+605.9%
0.00%
Q2 2021$7,000
-86.5%
1,671
-83.6%
0.00%
Q1 2021$52,000
+136.4%
10,166
+90.9%
0.00%
Q4 2020$22,0005,324
+12576.2%
0.00%
Q3 2020$0
-100.0%
42
-99.4%
0.00%
Q2 2020$41,000
+485.7%
7,447
+232.3%
0.00%
Q1 2020$7,000
+250.0%
2,241
+372.8%
0.00%
Q4 2019$2,000
-88.2%
474
-88.4%
0.00%
Q3 2019$17,000
-73.8%
4,099
-76.3%
0.00%
Q2 2019$65,000
-22.6%
17,260
-14.1%
0.00%
Q1 2019$84,000
+55.6%
20,100
-8.1%
0.00%
Q4 2018$54,000
+5300.0%
21,875
+5828.2%
0.00%
Q2 2018$1,000
-90.0%
369
-86.2%
0.00%
Q1 2018$10,000
-78.3%
2,665
-79.0%
0.00%
Q4 2017$46,000
-71.4%
12,680
-60.0%
0.00%
Q2 2017$161,000
+2583.3%
31,703
+3710.5%
0.00%
Q1 2017$6,000
-72.7%
832
-64.6%
0.00%
Q4 2016$22,000
-37.1%
2,353
-5.5%
0.00%
Q2 2016$35,000
+16.7%
2,490
+71.8%
0.00%
Q4 2014$30,0001,4490.00%
Other shareholders
APPLIED GENETIC TECHNOL CORP shareholders Q4 2020
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,404,515$1,081,0002.01%
SABBY MANAGEMENT, LLC 811,973$625,0000.42%
Portolan Capital Management 1,605,599$1,236,0000.12%
Knoll Capital Management, LLC 100,000$77,0000.04%
Shay Capital LLC 50,000$39,0000.01%
COLONY GROUP LLC 330,287$254,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 155,375$120,0000.00%
MILLENNIUM MANAGEMENT LLC 1,499,124$1,154,0000.00%
Virtu Financial LLC 10,807$8,0000.00%
FIDUCIARY TRUST CO 40,000$31,0000.00%
View complete list of APPLIED GENETIC TECHNOL CORP shareholders